Startseite/Aktien/VVOS

VVOS

USD

Vivos Therapeutics Inc. Common Stock

$2.360-0.050 (-2.075%)

Echtzeitkurs

Healthcare

Medizinprodukte

Vereinigte Staaten

Kursdiagramm

Loading Chart...

Schlüsselkennzahlen

Marktkennzahlen

Unternehmensfundamentaldaten

Handelsstatistiken

Marktkennzahlen

Eröffnung

$2.410

Hoch

$2.570

Tief

$2.350

Volumen

0.09M

Unternehmensfundamentaldaten

Marktkapitalisierung

17.7M

Branche

Medizinprodukte

Land

United States

Handelsstatistiken

Durchschnittliches Volumen

0.28M

Börse

NCM

Währung

USD

52-Wochen-Spanne

Tief $1.98Aktuell $2.360Hoch $7.95

Ähnliche Nachrichten

17. Sept. 2025 · 12:30

GlobeNewswire

Vivos Therapeutics Announces Landmark Clinical Trial Results in Pediatric Obstructive Sleep Apnea Treatment

LITTLETON, Colo., Sept. 17, 2025 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. ("Vivos" or the "Company'') (NASDAQ:VVOS), a leading medical device and technology company specializing in the development and

Vivos Therapeutics Announces Landmark Clinical Trial Results in Pediatric Obstructive Sleep Apnea Treatment

9. Sept. 2025 · 11:18

Analyst Upgrades

Ascendiant Capital Maintains Buy on Vivos Therapeutics, Raises Price Target to $6.5

Ascendiant Capital analyst Lucas Ward maintains Vivos Therapeutics with a Buy and raises the price target from $6.2 to $6.5.

Ascendiant Capital Maintains Buy on Vivos Therapeutics, Raises Price Target to $6.5

Ähnliche Aktien

AGNCN

AGNC Investment Corp. Depositary Shares Each Representing a 1/1000th Interest in a Share of 7.00% Series C Fixed-To-Floating Rate Cumulative Redeemable Preferred Stock

NASDAQ

Immobilien-Inve...